TY - JOUR
T1 - Beneficial plasma exchange response in central nervous system inflammatory demyelination
AU - Magaña, Setty M.
AU - Keegan, B. Mark
AU - Weinshenker, Brian G.
AU - Erickson, Bradley J.
AU - Pittock, Sean J.
AU - Lennon, Vanda A.
AU - Rodriguez, Moses
AU - Thomsen, Kristine
AU - Weigand, Stephen
AU - Mandrekar, Jay
AU - Linbo, Linda
AU - Lucchinetti, Claudia F.
PY - 2011/7
Y1 - 2011/7
N2 - Background: Plasma exchange (PLEX) is a beneficial rescue therapy for acute, steroid-refractory central nervous system inflammatory demyelinating disease (CNSIDD). Despite the approximately 45% PLEX response rate reported among patients with CNS-IDD, determinants of interindividual differences in PLEX response are not well characterized. Objective: To perform an exploratory analysis of clinical, radiographic, and serological features associated with beneficial PLEX response. Design: Historical cohort study. Setting: Neurology practice, Mayo Clinic College of Medicine, Rochester, Minnesota. Patients: All Mayo Clinic patients treated with PLEX between January 5, 1999, and November 12, 2007, for a steroid-refractory CNS-IDD attack. Main Outcome Measure: The PLEX response in attack-related, targeted neurological deficit(s) assessed within the 6-month period following PLEX. Results: Weidentified 153 patients treated with PLEX for a steroid-refractory CNS-IDD, of whom 90 (59%) exhibited moderate to marked functional neurological improvement within 6 months following treatment. Pre-PLEX clinical features associated with a beneficial PLEX response were shorter disease duration (P=.02) and preserved deep tendon reflexes (P=.001); post-PLEX variables included a diagnosis of relapsing-remitting multiple sclerosis (P=.008) and a lower Expanded Disability Status Scale score (P<.001) at last follow-up. Plasma exchange was less effective for patients with multiple sclerosis who subsequently developed a progressive disease course (P=.046). Radiographic features associated with a beneficial PLEX response were presence of ring-enhancing lesions (odds ratio=4.00; P=.03) and/or mass effect (odds ratio=3.00; P=.02). No association was found between neuromyelitis optica-IgG serostatus and PLEX response. Conclusions: We have identified clinical and radiographic features that may aid in identifying patients with fulminant, steroid-refractory CNS-IDD attacks who are more likely to respond to PLEX.
AB - Background: Plasma exchange (PLEX) is a beneficial rescue therapy for acute, steroid-refractory central nervous system inflammatory demyelinating disease (CNSIDD). Despite the approximately 45% PLEX response rate reported among patients with CNS-IDD, determinants of interindividual differences in PLEX response are not well characterized. Objective: To perform an exploratory analysis of clinical, radiographic, and serological features associated with beneficial PLEX response. Design: Historical cohort study. Setting: Neurology practice, Mayo Clinic College of Medicine, Rochester, Minnesota. Patients: All Mayo Clinic patients treated with PLEX between January 5, 1999, and November 12, 2007, for a steroid-refractory CNS-IDD attack. Main Outcome Measure: The PLEX response in attack-related, targeted neurological deficit(s) assessed within the 6-month period following PLEX. Results: Weidentified 153 patients treated with PLEX for a steroid-refractory CNS-IDD, of whom 90 (59%) exhibited moderate to marked functional neurological improvement within 6 months following treatment. Pre-PLEX clinical features associated with a beneficial PLEX response were shorter disease duration (P=.02) and preserved deep tendon reflexes (P=.001); post-PLEX variables included a diagnosis of relapsing-remitting multiple sclerosis (P=.008) and a lower Expanded Disability Status Scale score (P<.001) at last follow-up. Plasma exchange was less effective for patients with multiple sclerosis who subsequently developed a progressive disease course (P=.046). Radiographic features associated with a beneficial PLEX response were presence of ring-enhancing lesions (odds ratio=4.00; P=.03) and/or mass effect (odds ratio=3.00; P=.02). No association was found between neuromyelitis optica-IgG serostatus and PLEX response. Conclusions: We have identified clinical and radiographic features that may aid in identifying patients with fulminant, steroid-refractory CNS-IDD attacks who are more likely to respond to PLEX.
UR - http://www.scopus.com/inward/record.url?scp=79960186525&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960186525&partnerID=8YFLogxK
U2 - 10.1001/archneurol.2011.34
DO - 10.1001/archneurol.2011.34
M3 - Article
C2 - 21403003
AN - SCOPUS:79960186525
SN - 0003-9942
VL - 68
SP - 870
EP - 878
JO - Archives of neurology
JF - Archives of neurology
IS - 7
ER -